Get notified when MCRB files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsSeres Therapeutics schedules 2026 annual meeting for June 9, sets stockholder proposal deadline
Filed March 16, 2026 · Period ending March 16, 2026 · ~1 min read
Key Changes
-
low
Annual stockholder meeting scheduled for June 9, 2026, with April 13, 2026 record date for voting eligibility. This is a routine corporate governance event with no immediate business impact.
Item 8.01 verify on EDGAR → -
low
Stockholder proposals for inclusion in proxy materials must be received by March 26, 2026. The accelerated deadline reflects the meeting being held more than 30 days after last year's anniversary date.
Item 8.01 verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (TRV 10-Q) is open in full — no account needed.
Partner
Trade MCRB commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 4, 2026 · How we verify